For research use only. Not for therapeutic Use.
6α,9α-Difluoroprednisolone 21-Acetate(Cat No.:R022419) is a high-purity synthetic glucocorticoid with potent anti-inflammatory and immunosuppressive properties. Used primarily in pharmaceutical research and medicine, it helps manage conditions like allergies, asthma, and autoimmune disorders. This compound is a fluorinated derivative of prednisolone, enhancing its efficacy and metabolic stability. Its precise activity in modulating the immune response and reducing inflammation makes it crucial for developing new therapies for inflammatory diseases. 6α,9α-Difluoroprednisolone 21-Acetate is essential for advancing research in corticosteroid pharmacology and improving clinical treatments.
Catalog Number | R022419 |
CAS Number | 52-70-0 |
Synonyms | (6α,11β)-21-(Acetyloxy)-6,9-difluoro-11,17-dihydroxypregna-1,4-diene-3,20-dione; 6α,9-Difluoro-11β,17,21-trihydroxypregna-1,4-diene-3,20-dione; |
Molecular Formula | C23H28F2O6 |
Purity | ≥95% |
Storage | -20°C |
IUPAC Name | [2-[(6S,8S,9R,10S,11S,13S,14S,17R)-6,9-difluoro-11,17-dihydroxy-10,13-dimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate |
InChI | InChI=1S/C23H28F2O6/c1-12(26)31-11-19(29)22(30)7-5-14-15-9-17(24)16-8-13(27)4-6-20(16,2)23(15,25)18(28)10-21(14,22)3/h4,6,8,14-15,17-18,28,30H,5,7,9-11H2,1-3H3/t14-,15-,17-,18-,20-,21-,22-,23-/m0/s1 |
InChIKey | LAAFISZDLHQNFS-WGFKBPOKSA-N |
SMILES | CC(=O)OCC(=O)C1(CCC2C1(CC(C3(C2CC(C4=CC(=O)C=CC43C)F)F)O)C)O |